Learn more

UNIV EMORY

Overview
  • Total Patents
    3,003
  • GoodIP Patent Rank
    1,884
  • Filing trend
    ⇩ 31.0%
About

UNIV EMORY has a total of 3,003 patent applications. It decreased the IP activity by 31.0%. Its first patent ever was published in 1983. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UNIV CHINA MEDICAL, UNIV GEORGETOWN and UNIV VIRGINIA COMMONWEALTH.

Patent filings per year

Chart showing UNIV EMORYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Liotta Dennis C 361
#2 Schinazi Raymond F 241
#3 Hunter Robert L 125
#4 Choi Woo-Baeg 100
#5 Snyder James P 86
#6 Lollar John S 83
#7 Ye Keqiang 61
#8 Bluemling Gregory R 61
#9 Nie Shuming 61
#10 Traynelis Stephen F 60

Latest patents

Publication Filing date Title
US2021106547A1 Managing Cardiovascular Conditions Associated with Kidney Disease
US2021093597A1 KRAS Agonists, Pharmaceutical Compositions, and Uses in Managing Cancer
WO2021062012A1 Use of klk10 and engineered derivatizations thereof
WO2021050721A1 Quinoline derivatives and uses in managing cancer
WO2021046342A1 Systems and methods for detecting sleep activity
US2021059683A1 Methods and Devices Configured to Prevent Aspiration
WO2021041891A1 Use of deoxycholic acid, derivatives, or salts thereof in managing bacterial infections and compositions related thereto
WO2021035214A1 Nucleoside prodrugs and uses related thereto
US2021041853A1 Systems, Devices, and Methods for Generating a Model of a Vascular Network, and for Analyzing and/or Treatment Planning Related to Thereof
US2021022726A1 Orthopedic Fixation Devices and Methods
WO2021055081A1 Endothelial and smooth muscle like tissue produced from urine cells and uses related thereto
WO2021007512A1 Platinum-based chemotherapy, mast binding agents, glucocorticoid receptor (gr) binding agents, and/or hsp90 binding agents for uses in treating cancer
WO2021007499A1 Combination therapies for managing cancer
WO2021007312A1 Systems and methods for determining antimicrobial resistance of a sample using surface topography determined from optical imaging data
WO2021040880A1 Systems and methods for correcting intravoxel and/or voxel inhomogeneity and/or standardizing steady-state signal
US2021024985A1 Devices and Methods Useful for Imaging Transient and Rare Mechanical Events in Cells
WO2020247914A1 Kras g12v mutant binds to jak1, inhibitors, pharmaceutical compositions, and methods related thereto
WO2020247598A1 Photolysis to unlock caged protein therapeutics
WO2020247665A1 Peptidomimetics for the treatment of coronavirus and picornavirus infections
WO2020242933A1 Asparagine endopeptidase (aep) inhibitors, compositions, and uses related thereto